Wait… Weight, What? Getting the Skinny on GLP-1s for Weight Management

S01 E01: Wait… Weight, What? Getting the Skinny on GLP-1s for Weight Management

 

“Why is weight-loss achievement the holy grail of drug development?”

In the premiere episode of Pharmland, co-hosts Bradley Nelson and Tom Davies talk with RxBenefits clinical pharmacist Langley Kyle, PharmD, about the use of GLP-1 drugs for weight-loss purposes — and discuss society’s changing attitudes toward obesity. As the healthcare industry comes to recognize obesity as a treatable health condition rather than a personal failing, plan sponsors find themselves examining their position on covering weight-loss medications as a class. And as GLP-1s originally indicated for type 2 diabetes are increasingly used for weight-management purposes, that decision — to cover, or not to cover? — becomes increasingly pricey.

 

Guest:

Langley Kyle, PharmD, Director, Clinical Services

 

Co-hosts:

Bradley Nelson, PharmD, Vice President, Clinical Services

Tom Davies, PharmD, Vice President, Clinical Products